Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
03/2007
03/28/2007CN1307421C Method and compositions for overcoming resistance to biologic and chemotherapy
03/27/2007US7196069 High affinity RNA ligands of basic fibroblast growth factor
03/27/2007US7195880 DNA-protein fusions and uses thereof
03/27/2007US7195874 Using conjugate agents comprise of photoreactive moiety to identify preferential micro and/or macromolecules in heterologous mixtures
03/22/2007WO2004009837A3 A high resolution typing system for pathogenic mycobacterium tuberculosum
03/22/2007US20070066815 Selective O-acylation of nucleosides
03/22/2007US20070066560 Partial and full agonists of A1 adenosine receptors
03/22/2007US20070065922 Biocatalytic synthesis of aminodeoxy purine N9-beta-D-nucleosides containing 3-amino-3-deoxy-beta-D-ribofuranose, 3-amino-2,3-dideoxy-beta-D-ribofuranose, and 2-amino-2-deoxy-beta-D-ribofuranose as sugar moieties
03/21/2007EP1697394B1 Comt inhibitors
03/21/2007EP1100513B1 Method for producing autoinducer synthase
03/21/2007CN1931869A Derivative of 5-deoxy-5-fluoro cytidine and its prepn process and use
03/20/2007US7193077 Forming an internucleotide bond by contacting a nucleoside moiety having a reactive site hydroxyl with a precursor having an exocyclic amine triaryl protecting group; solid phase synthesis; by-product inhibition; greater monomer solubility in anhydrous solvents
03/20/2007US7192936 Use treating hepatitis C infection optionally with other viricides such as interferons or ribavirin; low toxicity to the host; use of cytosine-based nucleotides or nucleosides having a 2'-trifluoromethyl-ribose moiety which forms a 5'-phosphate or hydroxy moiety in vivo
03/20/2007US7192932 Use of immunomodulating agents
03/15/2007WO2007029364A1 2’-deoxyguanosine hybrid compound containing pyrrole amide tetramer, method of producing the same and production intermediate therefor
03/15/2007WO2007029082A2 An improved fermentation process for preparing ascomycin
03/15/2007US20070060745 Process for the preparation of fludarabine phosphate
03/15/2007US20070060744 Process for the synthesis of pyrazolopyrimidines
03/15/2007US20070060541 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
03/15/2007US20070060505 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
03/15/2007US20070060504 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
03/15/2007US20070060503 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
03/15/2007US20070060498 2' and 3'-Prodrugs of 1', 2', 3' or 4'-branched beta -D or beta -L nucleosides provide superior results against flaviviruses and pestiviruses, including hepatitis C virus and viruses that replicate through an RNA dependent RNA reverse transcriptase; administering interferons as second antivirus agent
03/15/2007CA2621104A1 2'-deoxyguanosine hybrid compound containing pyrrole amide tetramer, method of producing the same and production intermediate therefor
03/14/2007EP1761551A1 Gemcitabine derivatives nanoparticles
03/14/2007EP1552007A4 Multiplex genotyping using solid phase capturable dideoxynucleotides and mass spectrometry
03/14/2007EP1178999B1 L-ribo-lna analogues
03/14/2007EP1095947B1 Novel antibacterial compounds
03/14/2007CN1304409C Process for producing indolopyrrolocarbazole derivative
03/14/2007CN1304408C Derivative of vibothymidine and its preparation process and application
03/14/2007CN1304406C Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
03/13/2007US7189834 Oligoribonucleotides (ORNs) that are stress response factors from bacteria for use as immunostimulants in animals to withstand microbial infections and the lethality of endotoxic shock
03/13/2007US7189706 C2,5′-disubstituted and N6,C2,5′-trisubstituted adenosine derivatives and pharmaceutical compositions containing them
03/13/2007CA2387533C Purine derivatives
03/13/2007CA2176181C D4t polymorphic form i process
03/08/2007WO2007027564A2 Process for preparing gemcitabine and associated intermediates
03/08/2007WO2006097320A3 Macromolecular nucleotide links and methods for their use
03/07/2007EP1758916A1 3-BETA-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
03/07/2007EP1758915A2 Composition and method for inhibiting platelet aggregation
03/07/2007EP1758596A2 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
03/07/2007EP1337541B1 Massive parallel method for decoding DNA and RNA
03/07/2007EP1257695B1 Biomolecules having multiple attachment moieties for binding to a substrate surface
03/07/2007EP1061922B9 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
03/07/2007CN1923365A Method for producing indolopyrrolocarbazole derivative
03/07/2007CN1303094C Improved method for preparing anti-parasite preparation
03/06/2007CA2389264C Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives
03/06/2007CA2219132C Nucleosides with anti-hepatitis b virus activity
03/01/2007WO2006130217A3 Substituted phosphate esters of nucleoside phosphonates
03/01/2007US20070049741 For condensing DNA; ion exchanging
02/2007
02/28/2007EP1756313A2 Sequence-specific detection of methylation in biomolecules
02/28/2007EP1755391A2 Methods and compositions for treating neuropathies
02/28/2007EP1119577B1 Synthesis of oligonucleotides, reagents and methods related thereto
02/28/2007CN1922196A Crystalline forms of a pharmaceutical compound
02/28/2007CN1919860A Synthesis of 2'-deoxy-l-nucleosides
02/28/2007CN1919859A Synthesis of 2'-deoxy-l-nucleosides
02/28/2007CN1919858A Synthesis of 2'-deoxy-l-nucleosides
02/28/2007CN1919852A Methods of purifying phosphitylated compounds
02/28/2007CN1919201A Compounds and methods for therapeutic intervention in preventing diabetic complications
02/28/2007CN1302004C Preparing method for cytarabine
02/27/2007US7183406 Method for the synthesis of DNA sequences
02/27/2007US7183264 Such as ethyl-1-(9-((4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxy-methyl)oxolan-2-yl)-6 -aminopurin-2-yl)pyrazole-4-carboxylate; adenosine receptors (A2A); for stimulating mammalian coronary vasodilatation for therapy and imaging the heart
02/27/2007US7183253 Substantially pure glycopeptide antibiotics AC-98-1, AC-98-2, AC-98-3, AC-98-4 and AC-98-5
02/22/2007WO2006033709A8 Novel nucleoside derivatives
02/22/2007US20070042990 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
02/22/2007US20070042989 Novel 2'-C-methyl nucleoside derivatives
02/22/2007US20070042988 (S)-2-{[(2R,3S,4R,5R)-5-(4-Amino-2-oxo-2H-pyrimidin-1-yl)-2-azido-3,4-dihydroxy-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-3-phenyl-propionic acid ethyl ester, for example; treatment of Hepatitis C Virus (HCV) mediated diseases
02/22/2007US20070042987 Stereoselective synthesis of beta-nucleosides
02/22/2007US20070042975 Novel indolopyrrolocarbazole derivative with antitumor activity
02/22/2007US20070042939 Hepatitis C; antivirals; 8-modified,1', 2', 3' or 4'-branched purine nucleoside; treating HCV infection
02/22/2007CA2618335A1 Antiviral phosphoramidates of 4'-substituted pronucleotides
02/21/2007EP1754711A1 Process for producing indolopyrrolocarbazole derivative
02/21/2007EP1754710A2 2'-Fluoroncucleosides
02/21/2007EP1754482A1 Use of an ascomycin for the treatment of blepharitis
02/21/2007EP1753774A2 2"-nitrobenzyl-modified ribonucleotides
02/21/2007EP1601793A4 Methods for detection of genetic disorders
02/21/2007EP1290006B1 Combinatorial production of nucleotide and nucleoside (XITP) analogues
02/21/2007EP1137812B1 Dna-protein fusions and uses thereof
02/20/2007US7179906 Asymmetric benzoxanthene dyes
02/20/2007US7179905 Nucleic acid labeling compounds
02/20/2007US7179794 Antibiotics; bactericides
02/20/2007US7179591 Biosynthesis
02/20/2007US7179493 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
02/20/2007CA2422374C Purine derivatives
02/20/2007CA2335520C Adenosine derivatives
02/15/2007WO2007018259A1 Method for purification of cytidinediphosphoric choline
02/15/2007WO2006100087A3 Solid oral dosage form of valopi citabine (val-mcyd) and method of preparing it
02/15/2007WO2006078752A3 Inhibitors of dna methyltransferase
02/15/2007US20070037774 Novel cytarabine monophosphate prodrugs
02/15/2007US20070037773 Methods and compositions for treating flaviviruses and pestiviruses
02/15/2007US20070037771 Process for preparing branched ribonucleosides from 1,2-anhydroribofuranose intermediates
02/15/2007US20070037770 Oligonucleotide N3'-P5' thiophosphoramidates: their synthesis and use
02/15/2007US20070037735 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
02/15/2007DE102005035461A1 Stabile NAD/NADH-Derivate Stable NAD / NADH derivatives
02/15/2007CA2633565A1 Pharmaceutical compositions of silicon-containing substituted adenosine nucleoside amide analogs
02/14/2007EP1751172A1 Novel 3-triazolyl-galactoside inhibitors of galectins
02/14/2007CN1911953A Podophyllum kind compound and its use
02/14/2007CN1911952A Preparation technology of 18F labelled positive electron radioactivity tracer precusor
02/14/2007CN1911921A Method for identification of tumor targeting enzymes
02/14/2007CN1911237A Beta - l-2'-deoxy-nucleosides for the treatment of hepatitis b
02/14/2007CN1300165C 3-b-d-ribofuranosylthiazolo [4,5-d] pyridimine nucleosides and uses thereof
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 201